K

Kaken Pharmaceutical Co Ltd
TSE:4521

Watchlist Manager
Kaken Pharmaceutical Co Ltd
TSE:4521
Watchlist
Price: 4 376 JPY 0.3% Market Closed
Market Cap: 165.7B JPY
Have any thoughts about
Kaken Pharmaceutical Co Ltd?
Write Note

Cash Flow Statement

Cash Flow Statement
Kaken Pharmaceutical Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: JPY
Dec-2005 Jun-2006 Dec-2006 Jun-2007 Dec-2007 Jun-2008 Dec-2008 Jun-2009 Dec-2009 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Sep-2011 Mar-2012 Sep-2012 Mar-2013 Sep-2013 Mar-2014 Sep-2014 Mar-2015 Sep-2015 Mar-2016 Sep-2016 Mar-2017 Sep-2017 Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Mar-2021 Sep-2021 Mar-2022 Sep-2022 Mar-2023 Sep-2023 Mar-2024
Operating Cash Flow
Net Income
1 045
19
492
983
1 657
355
728
(111)
1 199
1 160
4 164
1 445
3 450
14 242
14 566
14 265
14 178
13 975
15 496
16 963
18 611
28 480
35 292
32 942
31 092
30 400
27 686
24 696
24 922
26 054
26 592
23 334
18 657
17 728
13 885
12 678
6 817
4 246
9 796
Depreciation & Amortization
(2)
17
36
4
209
69
92
39
37
(48)
555
12
697
2 538
2 424
2 467
2 607
2 607
2 538
2 486
2 400
2 264
2 242
2 106
1 937
2 077
2 124
2 117
2 153
2 249
2 312
2 310
2 318
2 418
2 486
2 500
2 568
2 732
2 753
Other Non-Cash Items
(452)
(603)
(955)
94
(516)
182
1 320
(63)
(489)
190
285
(97)
215
801
857
741
499
453
(132)
(412)
1 055
1 076
(140)
(164)
(392)
(426)
(130)
(136)
155
383
421
(248)
(824)
(601)
2 515
2 969
1 515
1 236
(287)
Cash Taxes Paid
2 319
(1 996)
(3 366)
2 553
3 875
(652)
(368)
557
804
(536)
(532)
(629)
(630)
5 520
6 275
6 067
6 318
5 537
5 128
6 143
6 443
6 594
6 752
11 307
13 846
8 432
7 078
8 902
9 065
8 178
7 807
6 630
5 516
4 914
4 431
4 575
4 409
4 045
3 788
Cash Interest Paid
(18)
(75)
(212)
12
22
2
4
4
(24)
(5)
11
(20)
(2)
70
70
71
65
62
45
29
28
27
27
25
21
18
16
16
17
17
17
17
17
17
17
17
17
17
17
Change in Working Capital
(4 616)
3 585
4 819
(3 052)
(5 052)
1 526
(2 546)
(2 391)
(189)
174
178
48
3 191
(5 697)
(7 564)
(6 528)
(5 555)
(4 695)
(4 239)
(8 450)
(7 329)
(9 709)
(10 329)
(12 671)
(17 311)
(11 338)
(7 978)
(9 020)
(6 102)
1 058
(1 858)
(6 894)
(5 772)
(6 423)
(5 549)
(3 818)
(1 647)
(5 632)
(9 685)
Cash from Operating Activities
(4 025)
N/A
3 018
N/A
4 392
+46%
(1 971)
N/A
(3 702)
-88%
2 132
N/A
(406)
N/A
(2 526)
-522%
558
N/A
1 476
+165%
5 182
+251%
1 408
-73%
7 553
+436%
11 884
+57%
10 283
-13%
10 945
+6%
11 729
+7%
12 340
+5%
13 663
+11%
10 587
-23%
14 737
+39%
22 111
+50%
27 065
+22%
22 213
-18%
15 326
-31%
20 713
+35%
21 702
+5%
17 657
-19%
21 128
+20%
29 744
+41%
27 467
-8%
18 502
-33%
14 379
-22%
13 122
-9%
13 337
+2%
14 329
+7%
9 253
-35%
2 582
-72%
2 577
0%
Investing Cash Flow
Capital Expenditures
63
(151)
(465)
(217)
(324)
(194)
(475)
357
40
182
(2 140)
(1 341)
(2 954)
(4 104)
(2 529)
(3 386)
(3 914)
(2 612)
(2 126)
(1 782)
(2 028)
(2 881)
(3 217)
(2 855)
(2 354)
(1 672)
(1 888)
(2 050)
(2 128)
(2 681)
(2 202)
(1 844)
(2 286)
(2 989)
(3 257)
(2 851)
(2 206)
(1 867)
(2 167)
Other Items
(1)
(279)
(159)
257
995
163
(304)
(148)
176
40
40
(902)
(1 732)
(1 279)
(34)
(608)
(2 878)
(2 297)
(9)
4
2 501
2 395
(888)
(1 647)
(1 149)
(502)
(1 357)
(1 590)
(3 616)
(3 363)
(326)
545
642
451
(4 631)
(5 265)
(421)
(491)
(3 687)
Cash from Investing Activities
62
N/A
(430)
N/A
(624)
-45%
40
N/A
671
+1 578%
(31)
N/A
(779)
-2 413%
209
N/A
216
+3%
222
+3%
(2 100)
N/A
(2 243)
-7%
(4 686)
-109%
(5 383)
-15%
(2 563)
+52%
(3 994)
-56%
(6 792)
-70%
(4 909)
+28%
(2 135)
+57%
(1 778)
+17%
473
N/A
(486)
N/A
(4 105)
-745%
(4 502)
-10%
(3 503)
+22%
(2 174)
+38%
(3 245)
-49%
(3 640)
-12%
(5 744)
-58%
(6 044)
-5%
(2 528)
+58%
(1 299)
+49%
(1 644)
-27%
(2 538)
-54%
(7 888)
-211%
(8 116)
-3%
(2 627)
+68%
(2 358)
+10%
(5 854)
-148%
Financing Cash Flow
Net Issuance of Common Stock
(1 294)
(1 201)
(284)
1 785
(1 507)
8
1 406
1
1 725
1
(4 055)
(3 370)
(3 387)
(3 516)
(3 491)
(2 189)
(2 202)
(1 922)
(2 860)
(4 527)
(3 636)
(248)
(201)
(3 536)
(3 512)
(3 443)
(3 445)
(3 527)
(3 523)
(4 253)
(4 252)
(2 142)
(2 940)
(3 213)
(2 414)
(1 341)
(1 340)
(1)
0
Net Issuance of Debt
712
0
0
0
0
0
(1 170)
600
1 770
(600)
(600)
(720)
(720)
0
0
0
0
(4 170)
(4 195)
0
0
0
(320)
0
0
0
0
0
0
0
(25)
0
0
0
0
0
0
0
0
Cash Paid for Dividends
(215)
(201)
(404)
58
(257)
(103)
(361)
(268)
(419)
(91)
(372)
(343)
(369)
(3 296)
(3 413)
(3 532)
(3 664)
(3 795)
(3 936)
(4 066)
(4 263)
(4 886)
(5 463)
(6 037)
(6 288)
(6 128)
(6 085)
(6 043)
(6 001)
(5 957)
(5 896)
(5 838)
(5 811)
(5 766)
(5 714)
(5 675)
(5 649)
(5 627)
(5 657)
Other
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(1)
(1)
0
(1)
(2)
0
(1)
0
0
0
0
0
(1)
0
0
0
(1)
(1)
(1)
(1)
0
(1)
0
(1)
Cash from Financing Activities
(797)
N/A
(1 402)
-76%
(688)
+51%
1 843
N/A
(1 764)
N/A
(95)
+95%
(125)
-32%
333
N/A
3 076
+824%
(690)
N/A
(5 027)
-629%
(4 433)
+12%
(4 476)
-1%
(6 932)
-55%
(6 904)
+0%
(5 722)
+17%
(5 867)
-3%
(9 887)
-69%
(10 992)
-11%
(8 620)
+22%
(7 900)
+8%
(5 135)
+35%
(5 984)
-17%
(9 892)
-65%
(9 800)
+1%
(9 571)
+2%
(9 530)
+0%
(9 571)
0%
(9 524)
+0%
(10 209)
-7%
(10 173)
+0%
(8 006)
+21%
(8 752)
-9%
(8 980)
-3%
(8 129)
+9%
(7 016)
+14%
(6 990)
+0%
(5 629)
+19%
(5 658)
-1%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Change in Cash
(4 760)
N/A
1 186
N/A
3 080
+160%
(88)
N/A
(4 795)
-5 349%
2 006
N/A
(1 310)
N/A
(1 984)
-51%
3 850
N/A
1 008
-74%
(1 945)
N/A
(5 268)
-171%
(1 609)
+69%
(431)
+73%
816
N/A
1 229
+51%
(930)
N/A
(2 456)
-164%
536
N/A
189
-65%
7 310
+3 768%
16 490
+126%
16 976
+3%
7 819
-54%
2 023
-74%
8 968
+343%
8 927
0%
4 446
-50%
5 860
+32%
13 491
+130%
14 766
+9%
9 197
-38%
3 983
-57%
1 604
-60%
(2 680)
N/A
(803)
+70%
(364)
+55%
(5 405)
-1 385%
(8 935)
-65%
Free Cash Flow
Free Cash Flow
(3 962)
N/A
2 867
N/A
3 927
+37%
(2 188)
N/A
(4 026)
-84%
1 938
N/A
(881)
N/A
(2 169)
-146%
598
N/A
1 658
+177%
3 042
+83%
67
-98%
4 599
+6 764%
7 780
+69%
7 754
0%
7 559
-3%
7 815
+3%
9 728
+24%
11 537
+19%
8 805
-24%
12 709
+44%
19 230
+51%
23 848
+24%
19 358
-19%
12 972
-33%
19 041
+47%
19 814
+4%
15 607
-21%
19 000
+22%
27 063
+42%
25 265
-7%
16 658
-34%
12 093
-27%
10 133
-16%
10 080
-1%
11 478
+14%
7 047
-39%
715
-90%
410
-43%

See Also

Discover More